Sensodyne Maker Deploys Microsoft AI for Daily Health

UK consumer health company Haleon – which owns brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins – plans to scale its digital, data and AI capabilities with a new five-year collaboration with Microsoft.

Haleon operates in 170 markets across six categories, with its trusted brands reaching an estimated 1.4 billion consumers worldwide. 

Building on Haleon’s existing use of Microsoft 365 Copilot, this agreement accelerates the company-wide adoption of AI by empowering employees to automate administrative work, streamline collaboration and focus on high-value priorities. 

The companies will co-create high-impact AI use cases, which deliver value across multiple critical functions, from consumer insights and innovation to supply chain and commercial execution.

From the lab to the consumer

To better serve consumers’ daily health needs, Haleon is focusing on driving faster scientific breakthroughs and clinical content production. 

The initiative will also contribute to its marketing with highly personalised content while enabling smarter, data-driven decisions across the entire organisation. 

“This collaboration marks a major step forward in how we use digital, data and AI to deliver our global strategy – driving growth, improving productivity and building a more agile, performance-focused culture,” says Claire Dickson, Chief Digital and Technology Officer at Haleon.

“We’re already embedding AI capabilities across the business, delivering measurable results and efficiencies in areas including consumer insights, marketing, R&D and supply chain. 

“By combining Microsoft’s cloud and AI capabilities with Haleon’s deep consumer health expertise, we’re accelerating our AI progress – simplifying how we work, unlocking more value from our data, accelerating innovation and helping our teams make faster, smarter decisions to benefit our consumers.” 

Building a secure, enterprise-grade AI foundation

Haleon is using Microsoft Azure as its primary cloud platform and integrating Microsoft Copilot into its daily operations. 

This setup equips the company with the robust, scalable infrastructure and data analytics needed to compete in a digital-first market, all backed by enterprise-grade security. 

With reinforced identity protection and governance, Haleon can confidently protect its data and AI workflows while scaling its technology safely and responsibly. 

“Haleon is moving with real pace and purpose on its AI journey, using Microsoft cloud and AI capabilities to turn ambition into impact across the entire organisation,” says Darren Hardman, CEO of Microsoft UK and Ireland. 

“From consumer insights and marketing to R&D, supply chain and decision-making, Haleon is already showing how AI can help teams work smarter, innovate faster and deliver meaningful benefits for consumers. 

“We’re proud to support Haleon as it scales AI securely and responsibly, helping the company unlock more value from its data and accelerate its mission to deliver better everyday health to millions more people around the world.”